PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment
NCT07024836 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 430
Last updated 2025-06-17
Summary
This study is part of a broader programme of work to develop and pilot a randomised-controlled trial of new tests to identify people who will benefit most from preventive treatment for tuberculosis (TB). The aim of the current study is to explore factors affecting patient decisions to start preventive treatment. The specific objectives are to understand how patients make decisions about preventive treatment initiation for TB (stage 1); and to design and conduct a "discrete choice experiment" survey to further evaluate preferences (stage 2).
Conditions
- Tuberculosis (TB)
Sponsors & Collaborators
-
University of Aberdeen
collaborator OTHER -
University College, London
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-22
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Prospective Assessment of TBDx Feasibility
NCT02912832 ·Status: COMPLETED ·Phase: NA
-
PanACEA - STEP2C -01
NCT05807399 ·Status: RECRUITING ·Phase: PHASE2
-
Lung Innate Immunity and Microbiome After Tuberculosis Exposure
NCT06526689 ·Status: RECRUITING
-
Rewards for Tuberculosis Contact Screening
NCT02234908 ·Status: COMPLETED ·Phase: NA
-
Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment Response
NCT03416309 ·Status: UNKNOWN
-
NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
NCT02371681 ·Status: COMPLETED ·Phase: PHASE2
-
Training Protocol on the Natural History of Tuberculosis
NCT01212003 ·Status: RECRUITING
-
Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081
NCT04608955 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
NCT05284812 ·Status: SUSPENDED ·Phase: PHASE2
-
Phase 2 Study of the ТВ/Flu-05Е Tuberculosis Vaccine
NCT06873282 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCG
NCT01242475 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried
NCT03026972 ·Status: COMPLETED ·Phase: PHASE1
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
AI-based System for Lung Tuberculosis Screening: Diagnostic Accuracy Evaluation
NCT05889364 ·Status: UNKNOWN
-
Assessing the Ability of the T-SPOT®.TB Test
NCT03929705 ·Status: COMPLETED
-
Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis
NCT06058299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts
NCT02454738 ·Status: COMPLETED ·Phase: NA
-
Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis?
NCT00214708 ·Status: WITHDRAWN
-
Evaluation of Tuberculosis Treatment Outcomes
NCT06942975 ·Status: COMPLETED
-
TuBerculosis Viability Interregional Study and Agreement on Biological Tests
NCT04968886 ·Status: UNKNOWN
-
Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB
NCT03350048 ·Status: COMPLETED
-
Comparison Between Two Strategies for the Diagnosis of TB
NCT02961569 ·Status: COMPLETED ·Phase: NA
-
Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines
NCT05592223 ·Status: COMPLETED ·Phase: PHASE1
-
Improving the Detection of Active Tuberculosis in Accident and Emergency Departments
NCT02512484 ·Status: UNKNOWN
-
A Pragmatic Randomised Study to Optimise Screening, Prevention and Care for Tuberculosis in Malawi
NCT03519425 ·Status: UNKNOWN ·Phase: NA